WallStreetZenWallStreetZen

NASDAQ: TNDM
Tandem Diabetes Care Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tandem Diabetes Care revenue was $940.20M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $282.6M, up 15.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNDM annual revenue was $940.2M, with 25.7% growth year-over-year.

TNDM past revenue growth

How has TNDM's revenue growth performed historically?

Company
25.74%
Industry
10.53%
Market
20.68%
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNDM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNDM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TNDM revenue history

Current Revenue
$940.2M
Current Earnings
-$96.0M
Current Profit Margin
-10.2%

Be the first to know when TNDM announces revenue.

TNDM Revenue History By Year

TNDM Yearly RevenueTNDM RevenueTNDM ChangeTNDM Revenue Growth
2024-12-31$940.20M$192.49M+25.74%
2023-12-31$747.72M-$53.50M-6.68%
2022-12-31$801.22M$98.42M+14.00%
2021-12-31$702.80M$203.97M+40.89%
2020-12-31$498.83M$136.53M+37.68%
2019-12-31$362.31M$178.44M+97.05%
2018-12-31$183.87M$76.27M+70.88%
2017-12-31$107.60M$23.35M+27.72%
2016-12-31$84.25M$11.40M+15.65%
2015-12-31$72.85M$23.13M+46.51%
2014-12-31$49.72M$20.72M+71.41%
2013-12-31$29.01M$26.53M+1,072.00%
2012-12-31$2.48MN/AN/A
2011-12-31$0.00N/AN/A

1 of 1

Tandem Diabetes Care Revenue FAQ

What was TNDM's revenue last quarter?

On Invalid Date, Tandem Diabetes Care (NASDAQ: TNDM) reported Q4 2024 revenue of $282.65 million up 43.62% year over year. In the same quarter last year, Tandem Diabetes Care's revenue was $196.80 million.

What was Tandem Diabetes Care's revenue in 2024?

Tandem Diabetes Care's annual revenue for the twelve months ending Dec 31, 2024 was $940.20 million, a 25.74% increase year over year.

How much does Tandem Diabetes Care make in a day?

Based on Tandem Diabetes Care annual revenue for the past five years, TNDM makes an average of $2,022,338.08 per day.

What was Tandem Diabetes Care's annual revenue growth in the past year?

As of Q2 2025, Tandem Diabetes Care's revenue has grown 25.74% year over year. This is 15.22 percentage points higher than the US Medical Devices industry revenue growth rate of 10.53%. Tandem Diabetes Care's revenue in the past year totaled $940.20 million.

How much does Tandem Diabetes Care make in a year?

Tandem Diabetes Care's revenue by year for the past five years is:
  • Tandem Diabetes Care's revenue for the twelve months ending Dec 31, 2024 was $940.20 million, a 25.74% increase year over year.
  • Tandem Diabetes Care's annual revenue for Dec 31, 2023 was $747.72 million, a 6.68% decrease from 2022.
  • Tandem Diabetes Care's annual revenue for 2022 was $801.22 million, a 14% increase from 2021.
  • Tandem Diabetes Care's annual revenue for 2021 was $702.80 million, a 40.89% increase from 2020.
  • Tandem Diabetes Care's annual revenue for 2020 was $498.83 million, a 37.68% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.